Clear Street’s Psyence Biomedical Warrant PBMWW Stock Holding History

Clear Street’s Portfolio PBMWW Stock Details PBMWW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.25K	Sell	257,202 -7	-0%	–	﹤0.01%	1253
2026 Q1	$4.68K	Hold	257,209	–	–	﹤0.01%	1007
2025 Q4	$4.76K	Sell	257,209 -109,356	-30%	-$2.76K	﹤0.01%	829
2025 Q3	$9.24K	Buy	366,565 +186,099	+103%	+$4.69K	﹤0.01%	688
2025 Q2	$3.66K	Hold	180,466	–	–	﹤0.01%	563
2025 Q1	$3.05K	Sell	180,466 -100	-0.1%	-$2	﹤0.01%	448
2024 Q4	$2.6K	Buy	180,566 +140	+0.1%	+$2	﹤0.01%	452
2024 Q3	$2.27K	Buy	180,426 +150	+0.1%	+$3	﹤0.01%	542
2024 Q2	$1.89K	Hold	180,276	–	–	﹤0.01%	608
2024 Q1	$12.6K	Buy	+180,276	New	+$11.2K	﹤0.01%	371

Other funds holding PBMWW

HCI

Harraden Circle Investments New York $784M AUM 20.59% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return

SCM

Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Clear Street's PBMWW Position: Q2 2026 in Review

Clear Street reduced its Psyence Biomedical Warrant (PBMWW) stake by 0% in Q2 2026, cutting 7 shares and leaving 257,202 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Clear Street first reported a position in PBMWW in Q1 2024 and has held it in 10 quarters since. The position peaked at $12.6K in Q1 2024. 18 funds tracked by Wall St. Rank hold PBMWW as of Q2 2026.

Clear Street held 257,202 shares of Psyence Biomedical Warrant worth $6.25K as of Q2 2026.
Clear Street sold 7 Psyence Biomedical Warrant shares in Q2 2026.
Psyence Biomedical Warrant made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #1253 holding.
Clear Street first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 10 quarters since.
Clear Street's Psyence Biomedical Warrant position peaked at $12.6K in Q1 2024.
18 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.